We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPABW
1701
CALL
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
$2.03M ﹤0.01%
200,000
GRML
1702
Greenland Mines Ltd
GRML
$29.9M
$2.03M ﹤0.01%
199,863
-802
-0.4% -$8.01K
FRBNW
1703
CALL
DELISTED
Forbion European Acquisition Corp. Warrants
FRBNW
$2.03M ﹤0.01%
196,203
DMYY
1704
DELISTED
dMY Squared
DMYY
$2.03M ﹤0.01%
+200,698
New +$2.01M
CTAS icon
1705
Cintas
CTAS
$86B
$2.02M ﹤0.01%
17,932
-70,952
-80% -$7.67M
FTAAW
1706
CALL
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
$2.02M ﹤0.01%
200,000
WAL icon
1707
Western Alliance Bancorporation
WAL
$9.13B
$2.02M ﹤0.01%
+33,938
New +$2.2M
ACRO.WS
1708
CALL
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
$2.01M ﹤0.01%
199,995
APGB.WS
1709
CALL
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$2.01M ﹤0.01%
200,739
CAMP
1710
DELISTED
CalAmp Corp.
CAMP
$2.01M ﹤0.01%
19,501
-13,820
-41% -$1.17M
BBY icon
1711
Best Buy
BBY
$18.9B
$2.01M ﹤0.01%
+25,037
New +$1.84M
BLEUW
1712
CALL
DELISTED
bleuacacia ltd Warrants
BLEUW
$2.01M ﹤0.01%
200,000
BGSX.WS
1713
CALL
DELISTED
Build Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
BGSX.WS
$2M ﹤0.01%
199,996
ZTAQW
1714
CALL
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$2M ﹤0.01%
200,572
KO icon
1715
PUT
Coca-Cola
KO
$380B
$1.98M ﹤0.01%
+31,200
New +$1.88M
TCMD icon
1716
Tactile Systems Technology
TCMD
$626M
$1.98M ﹤0.01%
172,833
-47,338
-22% -$417K
SATX.WS.A
1717
CALL
DELISTED
SatixFy Communications Ltd.
SATX.WS.A
$1.98M ﹤0.01%
+254,838
New +$107K
SANM icon
1718
Sanmina
SANM
$9.24B
$1.98M ﹤0.01%
+34,539
New +$2.04M
EXPE icon
1719
Expedia Group
EXPE
$35.5B
$1.97M ﹤0.01%
22,526
-293,506
-93% -$27.8M
COP icon
1720
CALL
ConocoPhillips
COP
$139B
$1.97M ﹤0.01%
16,700
-90,000
-84% -$10.9M
CCOI icon
1721
Cogent Communications
CCOI
$649M
$1.97M ﹤0.01%
34,515
+537
+2% +$29.5K
HOUS
1722
DELISTED
Anywhere Real Estate
HOUS
$1.96M ﹤0.01%
+307,336
New +$2.22M
SUI icon
1723
Sun Communities
SUI
$15.3B
$1.96M ﹤0.01%
13,723
-2,795
-17% -$382K
VAL icon
1724
Valaris
VAL
$5.16B
$1.96M ﹤0.01%
+28,972
New +$1.81M
FTAI icon
1725
FTAI Aviation
FTAI
$21.8B
$1.96M ﹤0.01%
+114,351
New +$1.92M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.